HRMY Harmony Biosciences Holdings, Inc.

NASDAQ
$39.57

Harmony Biosciences Holdings, Inc. (HRMY) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with HRMY's own trailing one-year pace, with 48% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 1 seller in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
3
13 transactions
Purchases
$0
0 shares
Sales
$6.0M
146,473 shares
Net activity
-$6.0M
purchases less sales

How much of that selling was preplanned? 48% planned / 52% discretionary

10b5-1 plan sales $2.8M 6 transactions · 74,067 shares
Discretionary sales $3.1M 7 transactions · 72,406 shares

Largest single sale: $1.5M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Budur Kumar CHIEF MEDICAL OFFICER Sell 35,852 $43.05 $1.5M 13,115 −73.2% of holding
Budur Kumar CHIEF MEDICAL OFFICER Sell 800 $43.00 $34.4K 13,115 −5.7% of holding
Budur Kumar CHIEF MEDICAL OFFICER Sell 1,800 $43.01 $77.4K 13,115 −12.1% of holding
Budur Kumar 3 fills CHIEF MEDICAL OFFICER Sell 28,454 $42.96 $1.2M 14,115 −66.8% of holding
Budur Kumar CHIEF MEDICAL OFFICER Sell 5,500 $41.98 $230.9K 18,615 −22.8% of holding
Kapadia Sandip CHIEF FINANCIAL OFFICER Sell 10b5-1 3,746 $37.15 $139.2K 24,521 −13.3% of holding
Kapadia Sandip CHIEF FINANCIAL OFFICER Sell 10b5-1 20,961 $35.92 $752.8K None left
Dayno Jeffrey M. 2 fills PRESIDENT, CEO Sell 10b5-1 25,933 $40.11 $1.0M None left
Kapadia Sandip CHIEF FINANCIAL OFFICER Sell 10b5-1 20,000 $39.54 $790.9K None left
Kapadia Sandip CHIEF FINANCIAL OFFICER Sell 10b5-1 3,427 $35.00 $119.9K None left

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.